HeraMED Limited announced it has executed its partnership agreement with leading provider of virtual care, eCare21, Inc., to integrate its technology into the eCare21 platform. On 16 September 2020, HeraMED announced that it had signed a letter of intent with eCare21. The immediate benefit of this agreement allows for the HeraMED solution to be marketed to eCare21's broad customer base of healthcare providers. Furthermore, this partnership will enable both parties to approach medical organisations, healthcare providers and doctors' clinics to accelerate awareness of HeraCARE and HeraBEAT in US. Commercial rollout is expected to follow a similar strategy of paid pilots before broader commercial rollout of the combined telehealth offering within a particular healthcare provider. Highlights: Partnership agreement executed with eCare21 enabling the HeraCARE platform and HeraBEAT device to be offered as part of the eCare21 platform. eCare21 is a leading telehealth and remote monitoring platform, marketed in collaboration with and powered by Dell Technologies Partnership is expected to accelerate awareness and take-up of HeraCARE and HeraBEAT in the US. Integration of HeraCARE into the eCare21 platform is already significantly advanced, basic functionality has been proven with final feature optimisation expected to be completed by the end of December 2020. Execution of agreement allows eCare21 and HeraMED to immediately pursue engagement with an established pipeline of healthcare providers Adoption of eCare21 solution to be validated through pilots then leading to broader rollout Partnership complements existing direct B2B strategy of driving adoption through clinical validation and endorsement by key opinion leaders. About the eCare21 Agreement: The key terms of the agreement which has an initial term of three years are as follows: Both eCare21 and HeraMED to market and deliver the HeraCARE platform as a Software as a Service (SaaS) solution via the eCare21 platform; HeraCARE subscriptions via eCare21 to be offered on similar commercial terms as if sold direct by HeraMED; Healthcare providers to pay an upfront establishment fee and a monthly per user subscription fee The integration work is already well progressed and expected to be completed by the end of December 2020, ensuring both parties can commence pilots for the existing pipeline of potential customers. This pipeline includes several eCare21 customers that are already using their virtual care platform for other areas of healthcare including primary care, cardiovascular care, diabetes management and senior care. The focus now, is on finalising the joint marketing, training, and onboarding materials for the imminent launch.